Intellirod Spine (formerly OrthoData Inc.) is developing disposable and implantable wireless RFID and microelectronic sensors to monitor strain on spinal fusion rods, enabling surgeons to objectively assess implanted hardware. The company’s products include LOADPRO™, an intra-operative sensor for monitoring rod strain during kyphotic correction surgery, and ACCUVISTA™, an implantable version. Intellirod has completed pre-clinical testing supporting an FDA application for ACCUVISTA and is recruiting patients for LOADPRO clinical studies in Louisville, Kentucky; Columbus, Ohio; and soon Cleveland, Ohio. The company is pursuing a de novo 510(k) pathway with the FDA and is simultaneously seeking a CE Mark for LOADPRO. Led by CEO Ric Navarro and based in Akron, Ohio, Intellirod plans to use new financing to reach commercialization milestones for its sensor technologies and related lumbar fusion implants. Intellirod Spine is an Akron, OH-based spinal implant company that develops disposable and implantable wireless RFID sensor technology to monitor spinal rod strains. Its implantable product, ACCUVISTA™, is targeted at monitoring post-operative strain in rods for degenerative disc disease fusion patients. The company recently completed pre-clinical testing in support of an FDA application for ACCUVISTA. Intellirod was formed in 2008 by University of Louisville professors and Dr. Rolando Puno and is led by CEO Ric Navarro. It intends to use new financing to reach key milestones toward commercialization of its sensor technologies and related lumbar fusion implants. OrthoData is an Akron, Ohio-based medical device company developing a diagnostic system for spine surgeons. Its core product is the IntelliRod™ system, an implantable microelectronic spine fusion sensor that enables surgeons to assess the success of spinal fusion procedures without exploratory surgery. Led by President and CEO Ric Navarro, the company is focused on completing prototype development. It plans to use the funds to complete prototype development and conduct relevant animal studies. The company raised $250K in the reported financing. The commitment came from Cleveland-based JumpStart, Inc.

Total raised

$1M

Funding rounds

3

Latest round

Equity

Latest activity

Jul 2016